| 000 | 01785 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514163510.0 | ||
| 264 | 0 | _c20040121 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0160-6689 | ||
| 024 | 7 |
_a10.4088/jcp.v64n1013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWinokur, Andrew | |
| 245 | 0 | 0 |
_aComparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cOct 2003 |
||
| 300 |
_a1224-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xadverse effects |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoxetine _xadverse effects |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMianserin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMirtazapine |
| 650 | 0 | 4 | _aPolysomnography |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDeMartinis, Nicholas A | |
| 700 | 1 | _aMcNally, Daniel P | |
| 700 | 1 | _aGary, Ellen M | |
| 700 | 1 | _aCormier, Jennifer L | |
| 700 | 1 | _aGary, Keith A | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 64 _gno. 10 _gp. 1224-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/jcp.v64n1013 _zAvailable from publisher's website |
| 999 |
_c14392933 _d14392933 |
||